Laboratory diagnosis of autoimmune diseases - New technologies, old dilemmas;Laboratorijska dijagnostika autoimunih bolesti - nove tehnologije, stare nedoumice

Biochemia Medica

Volumn 20, Issue 1, 2010, Pages 45-56

  Salamuni, Ilza ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Autoantibodies; Autoimmune diseases; Diagnostics; Standardization; Technologies

Indexed keywords

ANTIGEN; AUTOANTIBODY; ENZYME;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; AUTOIMMUNE DISEASE; BLOOD SAMPLING; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; HUMAN; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LABORATORY DIAGNOSIS; PROTEIN ANALYSIS; REVIEW; STANDARDIZATION; TECHNOLOGY;

EID: 77149172597     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Lernmark A. Autoimmune diseases: are markers ready for prediction? J Clin Invest 2001;108:1091-1096
2. González-Buitrago JM, González C. Present and future of the autoimmunity laboratory. Clin Chim Acta 2006;365:50-57
3. Hargraves M, Richmond H, Morton R. Presentation of two bone marrow components, the tact cell and the LE cell. Mayo Clin Proc 1948;27:25-28
4. Cook L. New Methods for Detection of Anti-nuclear Antibodies. Clin Immunol Immunopathol 1998;88:211-220
5. Rouquette AM, Desqruelles C, Larosche P. Evaluation of the new multiplexed immunoassays, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003;120:676-681
6. Hayashi N, Kawamoto T, Mukai M, Morinobu A, Koshiba M, Kondo S, et al. Detection of Antinuclear Antibodies by Use of an Enzyme Immunoassay with Nuclear Hep-2 Cell Extract and Recombinant Antigens: Comparison with Immunofluorescence Assay in 307 Patients. Clin Chem 2001;47:1649-1659
7. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-linked anti-immunoglobulin in antigen-coated tubes. J Immunol 1972;109:129-135
8. Balboni I, Chan SM, Kattah M, Tenenbaum JD, Butte AJ, Utz PJ. Multiplexed Protein Array Platforms for Analysis of Autoimmune Diseases. Annu Rev Immunol 2006;24:391-418.
9. Bossuyt X, Louche C, Wiik A. Standardisation in clinical laboratory medicine: an ethical reflection. Ann Rheum Dis 2008;8:1061-1063
10. Eissfeller P, Sticherling M, Scholz D, Hennig K, Lüttich T, Motz M, et al. Comparison of Different Test Systems for Simultaneous Autoantibody Detection in Connective Tissue Diseases. Ann NY Acad Sci 2005;1050: 1-13.
11. Bossuyt X, Frans J, Hendrickx A, Godefridis G, Westhovens R, Mariën G. Detection of Anti-SSA Antibodies by Indirect Immunofluorescence. Clin Chem 2004;12:2361-9.
12. Von PAJM, Bast EJEG, Derksen RHWM. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice. Reumatology 2006;45:629-635
13. Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the Laboratory Use of Autoantibody Tests in the Diagnosis and Monitoring of Autoimmune Rheumatic Diseases. Am J Clin Pathol 2002;117:314-324
14. Salamuni I, Paukovi-Sekuli B, Galetovi A, Tandara L, MartinoviKaliterna D. Comparative analysis of multiplex AtheNA Multi-Lyte ANA test system and conventional laboratory methods to detect autoantibodies. Biochem Med 2008;18:88-98.
15. Sturgess A, Edmonds J. Improving the effectiveness of autoantibody testing in the clinic. Autoimmun Rev 2002;1:273-278
16. Fritzler MJ. Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 2006;15:422-427
17. Ho man IEA, Peene I, Veys EM, De Keyser F. Detection of Specific Antinuclear Reactivities in Patients with Negative Anti-nuclear Antibody Immunofluorescence Screening Tests. Clin Chem 2002;48:2171-2176
18. Stinton LM, Fritzler MJ. A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders. Autoimmun Rev 2007;7:77-84.
19. Wiik AS. Anti-nuclear autoantibodies. Clinical utility for diagnosis, prognosis, monitoring, and planing strategy in systemic immunoinammatory diseases. Scand J Rheumatol 2005;34:260-268
20. Haass M, Lehmann HP. New aspects of autoantibody detection with a new combination of autoantigenic targets. Clin Applied Immunol Rev 2001;1:193-200.
21. Hieman R, Büttner T, Krieger T, Roggenbuck D. Challenges of automated screening and differentiation of non-organ Specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009;9:17-22.
22. Dahle C, Skogh T, Åberg AK, Jalal A, Olcén P. Methods of choice for diagnostics antinuclear antibody (ANA) screening: Benefit of adding antigen-Specific assays to immunofluorescence microscopy. J Autoimmun 2004;22:241-248
23. Orton SM, Peace-Brewer A, Schmitz JL, Freeman K, Miller WC, Folds JD. Practical Evaluation of Methods for Detection and Specificity of Autoantibodies to Extractable Nuclear Antigens. Clin Diagn Lab Immunol 2004;11:297-301.
24. Fenger M, Wiik A, Hoter-Madsen M, Lykkegaard JJ, Rozenfeld T, Hansen MS, et al. Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis. Clin Chem 2004;50:2141-2147
25. González C. Guevara P, Alarcón I, Hernando M, Navajo JA, González-Buitrago JM. Antinuclear antibodies (ANA) screening by enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: analytical and clinical evaluation. Clin Biochem 2002;35:463-469
26. Bizzaro N, Tozzoli R, Tonutti E, Piazza A, Manoni F, Ghirardello A, et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a Collaborative study with the biomedical indystry. J Immunol Methods 1998;219:99-107.
27. Binder SR. Autoantibody detection using multiplex technologies. Lupus 2006;15:412-421
28. Jaskowski TD, Schroder C, Martins TB, Mouritsen CL, Litwin CM, Hill HR. Screening for antinuclear antibodies by enzyme immunoassay. Am J Clin Pathol 1996;105:468-473
29. Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. Arthritis Rheum 1999;42:455-464
30. Friou CJ. Clinical application of lupus serum nucleoprotein reaction using fluorescent antibody technique. J Clin Invest 1957;36:890-897
31. Gonzalez C, Garcia-Berrocal B, Talavan T, Cassas ML, Navajo JA, Gonzalez-Buitargo JM. Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti thyroid peroxidase and anti thyroglobulin antibodies. Clin Biochem 2005;38:966-972
32. Gordon P, Khamashta MA, Rosenthal E, Simpson JM, Sharland G, Brucato A, et al. Anti-52 kDa Ro, Anti-60 kDa Ro, and Anti-La antibody pro les in neonathal lupus. J Rheumatol 2004;31:2480-2487
33. Joos TO, Stoll D, Templin MF. Miniaturised multiplexed immunoassays. Curr Opin Chem Biol 2001;6:76-80.
34. Wingren C, Borrebaeck CA. Antibody microarrays: current status and key technological advances. OMICS 2006;10:411-427
35. Gonzales-Buitrago JM. Multiplexed testing in the autoimmunity laboratory. Clin Chem Lab Med 2006;44:1169-1174
36. Rouquete AM, Desgruelles C, Laroche P. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003;120:676-681
37. FengY,KeX,MaR,ChenY,HuG,LiuF. Parallel Detection of Autoantibodies with Microarray in Rheumatoid Diseases.Clin Chem 2004;50:416-422
38. Seideman J, Peritt D. A novel monoclonal antibody screening method using the Luminex-100 microsphere system. J Immunol Methods 2002;267:165-171
39. Apweiler R, Aslandis C, Defuel T, Gerstner A, Hansen J, Hochstrasser D, et al. Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clin Chem Lab Med 2009;47:724-744
40. Robinson WH, Steinman L, Utz PJ. Proteomics technologies for the Study of Autoimmune Disease. Arthritis Rheum 2002;46:885-893 (Pubitemid 34303798)
41. Hueber W, Robinson WH. Proteomic biomarkers for autoimmune disease. Proteomics 2006;6:4100-4105
42. Tozzoli R, Bizzaro N, Tonutti E, Pradella M, Manoni F, Vilalta D. Immunoassay of Anti-Thyroid Autoantibodies: High Analytical Variability in Second Generation Methods. Clin Chem Lab Med 2002;40:568-573
43. Lukinac Lj, Krili D, Nöthig-Hus D, Kusi Z. The problem of thyroid antibodies testing. Acta Clin Croat 2004;43:355-359
44. Vergani D, Alvarez F, Bianchi FB, Cancado ELR, Mackay IR, Manns MP, et al. Liver autoimmune serology: a consesus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-683
45. Törn C, Mueller P, Schlosser M, Bonifacio E, Bingley P. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008;51:846-852
46. Rouquette AM, Desgruelles C. Detection of antibodies to dsDNA: an overview of laboratory assays. Lupus 2006;15:403-407
47. Fritzler MJ, Behmanesh F, Fritzler ML. Analysis of human sera that are polyreactive in an addressable laser bead immunoassay. Clin Immunol 2006;120:349-356
48. Biagini RE, Parks CG, Smith JP, Sammons DL, Robertson SA. Analytical performance of the AtheNA MultiLyte ANAII assay in sera from lupus patients with multiple positive ANAs. Anal Bioanal Chem 2007;388:613-618
49. Shovman O, Gilburd B, Barzilai O, Shinar E, Larida B, Zandman-Goddard G, et al. Evaluation of the BioPlex 2200 ANA Screen Analysis of 510 Healthy Subjects: Incidence of Natural/predictive autoantibodies. Ann NY Acad Sci 2005;1050:380-388
50. Avaniss-Aghajani E, Berzon S, Sarkissian A. Clinical Value of Multiplex Bead Based Immunoassay for Detection of Autoantibodies to Nuclear Antigens. Clin Vaccine Immunol 2007;14:505-509
51. Shovman O, Gilburd B, Zandman-Goddard G, Yehiley A, Langevitz P, Shoenfeld Y. Multiplexed AtheNA Multi-lyte immunoassay for ANA screening in autoimmune diseases. Autoimmunity 2005;38:105-109
52. Ni i AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. JIM 2006;311:189-197
53. Elshal MF, McCoy P. Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA. Methods 2006;38:317-323
54. Fritzler MJ, Wiik A, Fritzler ML, Barr SG. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 2003;5:192-201.
55. Chan EKL, Fritzler MJ, Wiik A, Andrade LEC, Reeves WH, Tincani A, Meroni PL. AutoAbSC. Org-Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007;6:377-380
56. Wiik A, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni PL, et al. European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. Lupus 2006;15:391-396
57. Dodig S. Interferences in quantitative immunochemical methods. Biochem Med 2009;19:50-62.